Medicilon Logo
|
search icon search icon language icon contact icon menu icon
Medicilon Logo
|
search icon close search icon language icon contact icon menu icon
CN
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
Medicilon Events
News and Events

Medicilon Events

Hot information:
Medicilon Appoints Dr. Liu Jian as President of Drug Discovery Division| Medicilon FTE services & FFS services - flexible and efficient cooperation model| Medicilon and Wuhan biolake successfully organized a biopharmaceutical salon
Oct 21,2021
Medicilon Symposium – "Preclinical Development Strategy of Innovative Drugs Driven by Translational Medicine" was Successfully Held
Shanghai Medicilon Inc. (Medicilon) and the summit organizer jointly held a symposium on PMIO China 2021 with the theme.
More
Medicilon Symposium – "Preclinical Development Strategy of Innovative Drugs Driven by Translational Medicine" was Successfully Held
Oct 18,2021
The Internationalization Trend of Chinese Pharmaceutical Companies and AI R&D Innovation Forum
Two forum themes, an inaugural meeting of Zhangjiang AI New Drug R&D Alliance Establishment, three keynote speeches, three rounds of roundtable discussion, a gathering of
More
The Internationalization Trend of Chinese Pharmaceutical Companies and AI R&D Innovation Forum
Oct 14,2021
Mr. Guolin Wang, Director and Secretary of the Board of Medicilon, won another award!
Recently, the selection of 2021 elite board secretaries of the Cai Lian She (CLS) and the Night of Qingdao Board Secretaries were held in Haitian
More
Mr. Guolin Wang, Director and Secretary of the Board of Medicilon, won another award!
Oct 12,2021
Join Medicilon at the AAPS 2021 PharmSci 360
Medicilon is looking forward to meeting you at this year's American Association of Pharmaceutical Scientists (AAPS) annual meeting—"PharmSci 360″. PharmSci 360 is an in-person meeting + virtual
More
Join Medicilon at the AAPS 2021 PharmSci 360
Oct 11,2021
Introduction to Medicilon's Chemistry and Biology Labs: Preclinical Drug Discovery and Development
https://www.youtube.com/embed/_dGe5Lbvkys
More
Introduction to Medicilon's Chemistry and Biology Labs: Preclinical Drug Discovery and Development
Oct 11,2021
Medicilon's CMC Services: Process and Formulation
Related Articles: The Value and Importance of Preformulation Research
More
Medicilon's CMC Services: Process and Formulation
Oct 11,2021
Video of Medicilon Preclinical Research Services
Related Articles: What is Preclinical Trails? Integrated Preclinical Trails Services New Drug Preclinical Trails
More
Video of Medicilon Preclinical Research Services
Oct 09,2021
Medicilon Won Four Heavyweight Awards in One Fell Swoop!
On September 28, the list of "15th China Listed Company Value Selection", sponsored by Securities Times and specially co-organized by Caitong Securities, was officially announced.
More
Medicilon Won Four Heavyweight Awards in One Fell Swoop!
Oct 09,2021
Medicilon won the "Science and Innovation Golden Horse Excellent Company Award " at the 2021 Science and Technology Leaders Summit
On July 22, 2019, the Shanghai Sci-Tech Innovation Board (STAR) opened.  Two years later, on July 22, 2021, 313 companies are listed on the STAR. 
More
Medicilon won the "Science and Innovation Golden Horse Excellent Company Award " at the 2021 Science and Technology Leaders Summit
Sep 22,2021
Medicilon is Listed on the Top Chinese R&D CRO Enterprises in 2021
Shanghai Medicilon Inc. (Medicilon) was invited to participate in this event and was awarded the Top Chinese R&D CRO Enterprises in 2021 .
More
Medicilon is Listed on the Top Chinese R&D CRO Enterprises in 2021
Sep 22,2021
Medicilon attended the 21st China International Fair for Investment and Trade
Medicilon attended the 21st China International Fair for Investment and Trade and signed a strategic collaboration agreement with Xiamen Biotime. The 21st China International Fair
More
Medicilon attended the 21st China International Fair for Investment and Trade
Sep 22,2021
Targeting IL-23, Medicilon Assists the Development of a Variety of New Drugs for Psoriasis
IL-23 is mainly produced by activated dendritic cells, macrophages and monocytes. It is a new member of the IL-12 heterodimeric cytokine family.
More
Targeting IL-23, Medicilon Assists the Development of a Variety of New Drugs for Psoriasis